Gilead’s liver disease drug selonsertib fails to meet primary endpoint in Stellar-4 study

Image: Gilead’s liver disease drug selonsertib has failed to meet primary endpoint in Stellar-4 study. Photo: courtesy of interphasesolution / FreeDigitalPhotos.net.